Enclara Pharmacia | February 26, 2020

Enclara Pharmacia Appoints Scott Quilty as Chief Commercial Officer


PHILADELPHIA – February 26, 2020 – Enclara Pharmacia, the market leader in comprehensive pharmacy management services to the hospice industry, announces the appointment of Scott Quilty as Chief Commercial Officer to drive Enclara’s strategic direction around business development, client services and marketing.

“I’m excited to welcome a leader of Scott’s caliber to our great team,” says Andy Horowitz, CEO of Enclara. “Scott has proven experience leading high performing organizations and achieving ambitious growth targets through cross-functional collaboration, innovation and organizational development.”

Quilty joins Enclara after over two decades with B. Braun Medical Inc., a leader in infusion therapy and pain management. He took on a variety of roles with increasing responsibility and scope culminating in his most recent position as Corporate Vice President.

“I am looking forward to continuing to help Enclara grow its already strong position as the hospice pharmacy and PBM market leader,” Quilty said. “Our recent acquisition by Humana presents many opportunities to better serve our clients and expand our offerings. Our ongoing expansion of same-day delivery through partnerships between couriers and local pharmacies will further increase our value proposition, especially as we work to leverage Humana’s owned pharmacies.”

About Enclara Pharmacia
Enclara Pharmacia is a national full-service PBM and mail order supplier of medications and clinical services developed specifically for the hospice and palliative care industry. Enclara services over 450 hospice providers and 97,000 patients nationally, helping to reduce pharmacy costs through a clinically driven model that enables home delivery of pharmaceuticals, as well as access to a network of over 65,000 retail pharmacies, including our own automated fulfillment pharmacies, and institutional pharmacies. To learn more about Enclara, visit www.enclarapharmacia.com.